Search research articles
Contact Us
Filters
Showing results (1-10 of 110) with videos related to
Page
of 11
Sort By:
Neuroscience Letters
|
April 18, 2002
An alternatively spliced form of rodent alpha-synuclein forms intracellular inclusions in vitro: role of the carboxy-terminus in alpha-synuclein aggregation
Pamela J McLean, Bradley T Hyman
CNS & Neurological Disorders Drug Targets
|
August 16, 2011
Drug targets from genetics: α-synuclein
Karin M Danzer, Pamela J McLean
Biological Psychiatry
|
October 27, 2015
Untangling a role for tau in synucleinopathies
Marion Delenclos, Simon Moussaud, Pamela J McLean
The New England Journal of Medicine
|
May 3, 2013
Proteotoxicity and cardiac dysfunction
Darius Ebrahimi-Fakhari, Pamela J McLean, Lara Wahlster
Journal of Parkinson'S Disease
|
January 27, 2012
Molecular chaperones in Parkinson's disease--present and future
Darius Ebrahimi-Fakhari, Lara Wahlster, Pamela J McLean
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|
July 26, 2012
Molecular chaperones and co-chaperones in Parkinson disease
Hemi Dimant, Darius Ebrahimi-Fakhari, Pamela J McLean
Acta Neuropathologica
|
June 30, 2012
Protein degradation pathways in Parkinson's disease: curse or blessing
Darius Ebrahimi-Fakhari, Lara Wahlster, Pamela J McLean
Neurobiology of Aging
|
December 7, 2014
Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction
Ming Gan, Simon Moussaud, Peizhou Jiang, et al.
Autophagy
|
February 4, 2012
Alpha-synuclein's degradation in vivo: opening a new (cranial) window on the roles of degradation pathways in Parkinson disease
Darius Ebrahimi-Fakhari, Pamela J McLean, Vivek K Unni
Biochemical and Biophysical Research Communications
|
November 4, 2004
A single amino acid substitution differentiates Hsp70-dependent effects on alpha-synuclein degradation and toxicity
Jochen Klucken, Youngah Shin, Bradley T Hyman, et al.
Page
of 11
Search research articles
Search
Showing results (1-10 of 110) with videos related to
Sort By:
Page
of 11
Neuroscience Letters
|
April 18, 2002
An alternatively spliced form of rodent alpha-synuclein forms intracellular inclusions in vitro: role of the carboxy-terminus in alpha-synuclein aggregation
Pamela J McLean, Bradley T Hyman
CNS & Neurological Disorders Drug Targets
|
August 16, 2011
Drug targets from genetics: α-synuclein
Karin M Danzer, Pamela J McLean
Biological Psychiatry
|
October 27, 2015
Untangling a role for tau in synucleinopathies
Marion Delenclos, Simon Moussaud, Pamela J McLean
The New England Journal of Medicine
|
May 3, 2013
Proteotoxicity and cardiac dysfunction
Darius Ebrahimi-Fakhari, Pamela J McLean, Lara Wahlster
Journal of Parkinson'S Disease
|
January 27, 2012
Molecular chaperones in Parkinson's disease--present and future
Darius Ebrahimi-Fakhari, Lara Wahlster, Pamela J McLean
The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry
|
July 26, 2012
Molecular chaperones and co-chaperones in Parkinson disease
Hemi Dimant, Darius Ebrahimi-Fakhari, Pamela J McLean
Acta Neuropathologica
|
June 30, 2012
Protein degradation pathways in Parkinson's disease: curse or blessing
Darius Ebrahimi-Fakhari, Lara Wahlster, Pamela J McLean
Neurobiology of Aging
|
December 7, 2014
Extracellular ATP induces intracellular alpha-synuclein accumulation via P2X1 receptor-mediated lysosomal dysfunction
Ming Gan, Simon Moussaud, Peizhou Jiang, et al.
Autophagy
|
February 4, 2012
Alpha-synuclein's degradation in vivo: opening a new (cranial) window on the roles of degradation pathways in Parkinson disease
Darius Ebrahimi-Fakhari, Pamela J McLean, Vivek K Unni
Biochemical and Biophysical Research Communications
|
November 4, 2004
A single amino acid substitution differentiates Hsp70-dependent effects on alpha-synuclein degradation and toxicity
Jochen Klucken, Youngah Shin, Bradley T Hyman, et al.
Page
of 11